Real estate investment and property services firm Onyx Equities and equity partner, Machine Investment Group, announced plans for the Northeast Science and Technology (NEST) Center in Kenilworth.
Formerly the global headquarters of Merck, Onyx purchased the state-of-the-art campus in February 2023 with an eye on the future of life sciences and biotechnology.
NEST Center co-founder and managing partner, John Saraceno, will share plans for the more than 2-million-square-foot purpose-built research and development campus while attending the BIO International Convention June 5-8 at the Boston Convention & Exhibition Center in Boston, Massachusetts. Initial project highlights will include:
NEST and other significant life science projects in New Jersey continue to help Onyx emerge as one of the sector’s new leaders. In fact, Kenvue, Johnson & Johnson’s billion-dollar consumer spinoff, recently selected an Onyx property to house its new global headquarters.
“The biotechnology industry has a high demand for both turnkey and customizable solutions,” noted Saraceno. “Prior to NEST, many health-tech companies, especially those in research and development, were forced to wait years for adequate laboratory and work space. NEST allows those on the cutting edge of medicine to focus on finding cures — rather than an office location.”
Saraceno went on to say that Onyx Equities chose to announce NEST at this year’s BIO Convention in Boston because the event has a reputation for bringing together leaders, innovators, and investors in the life science, biotech, and medical device industries with the goal of commemorating the value that breakthrough biotech performs for society.
To access more business news, visit NJB News Now.Related Articles: